Written and maintained by CASRAI Editorial Board
Last updated
Short answer
Fibroblasts are the connective-tissue cells that make the extracellular matrix (ECM) core components, including collagens and fibronectin. After injury they proliferate, lay down new matrix and drive scar formation, and in disease the same activity can turn into fibrosis. What a fibroblast does depends on its tissue, its activation state and its context.
Definition and scope
Virchow described fibroblasts as spindle cells of the connective tissue. They are mesoderm-derived and are normally semi-quiescent in healthy connective tissue (Roman, 2023). The fibroblast is the main cell type in mesenchymal tissues that produces the core components of the ECM, such as fibronectin and the collagens (Roman, 2023).
“Fibroblast” is a functional and morphological label, not a single uniform cell. Both reviews cited here stress that fibroblasts are heterogeneous in embryonic origin, plasticity and functionality (Knoedler et al., 2023; Roman, 2023). That is why a statement about “fibroblast functions” always needs a tissue and a context attached.
How fibroblasts work in practice
Building and maintaining the extracellular matrix
The structural role comes first: fibroblasts produce the matrix proteins that give connective tissue its framework. Fibronectin is among the earliest ECM proteins made by activated fibroblasts after an injury (Roman, 2023).
Wound healing
Healing begins with the invasion and proliferation of fibroblastic cells, followed by ECM deposition and scar formation and contraction (Roman, 2023). Knoedler and colleagues describe fibroblasts as having a pivotal role in all stages of wound healing, and note that skin-resident immune and stromal cells cross-communicate and initiate wound healing immediately after the injury (Knoedler et al., 2023).
Cross-talk with immune cells
Fibroblasts do not act alone. In the skin, the stromal and immune compartments signal to each other from the first moments after injury, so fibroblast behaviour in a wound is partly a response to, and a driver of, immune activity (Knoedler et al., 2023).
When repair goes wrong: fibrosis
Unregulated healing can lead to disease. The review by Roman gives idiopathic pulmonary fibrosis as an example, characterised by uncontrolled fibroblast proliferation and progressive fibrosis (Roman, 2023).
Function by context: a sourced summary
| Function | What the source states | Source |
|---|---|---|
| Matrix production | Main cell type in mesenchymal tissues producing core ECM components such as fibronectin and collagens | Roman, 2023 |
| Early injury response | Fibronectin is among the earliest ECM proteins made by activated fibroblasts | Roman, 2023 |
| Wound repair | Healing begins with invasion and proliferation of fibroblastic cells, then ECM deposition and scar formation and contraction | Roman, 2023 |
| All stages of healing | Fibroblasts carry a pivotal role in all stages of wound healing | Knoedler et al., 2023 |
| Immune cross-talk | Skin-resident immune and stromal cells cross-communicate and initiate wound healing immediately after injury | Knoedler et al., 2023 |
| Disease (fibrosis) | Idiopathic pulmonary fibrosis involves uncontrolled fibroblast proliferation and progressive fibrosis | Roman, 2023 |
Types: fibroblast populations and myofibroblasts
Fibroblast populations within one tissue
Skin shows the heterogeneity clearly. Papillary fibroblasts produce higher proportions of collagen VI alpha 1, collagen XVI, decorin and fibromodulin (Knoedler et al., 2023), and Philippeos and colleagues identified four distinct fibroblast populations in human skin samples (as reported in Knoedler et al., 2023).
Myofibroblasts
Myofibroblasts show features of both fibroblasts and smooth muscle cells, and alpha-smooth muscle actin (α-SMA) is the best-known marker (Roman, 2023).
Fibroblast-like cells from other origins
Fibroblast-like cells can also arise from other lineages. Knoedler and colleagues describe myeloid-to-fibroblast-like conversion after injury, and report that this phenotypic adaptability was dampened under diabetic conditions (Knoedler et al., 2023).
Where it matters for labs
For anyone choosing, culturing or reporting fibroblast models, the sources above point to a short checklist of context a “fibroblast function” claim depends on. It is a reporting checklist, not a protocol.
- Tissue of origin. Matrix output differs between fibroblast populations, for example papillary fibroblasts in skin (Knoedler et al., 2023).
- Activation state. Quiescent fibroblasts and activated or myofibroblast-like cells behave differently, and α-SMA is the best-known myofibroblast marker (Roman, 2023).
- Injury or disease context. Responses in healing differ from responses in fibrosis, and diabetic conditions have been reported to dampen myeloid-to-fibroblast-like adaptability (Knoedler et al., 2023).
- Population identity. Because several populations can coexist in one tissue, state which population or marker set you mean.
Practical lab context lives on other CASRAI pages: cell culture contamination covers keeping cultures usable, DMEM versus RPMI 1640 covers culture media, cell sorting settings and viability covers sorting cells (including a documented case of senescent human dermal fibroblasts, which failed on standard nozzles), and the CT26 cell line guide shows how a cell line’s identity is documented.
Common misunderstandings
“A fibroblast is one uniform cell type”
No. The reviews describe fibroblasts as a heterogeneous population of mesenchymal cells with distinct origins (Roman, 2023), with different embryonic origin, plasticity and functionality (Knoedler et al., 2023).
“A fibroblast and a myofibroblast are the same”
Myofibroblasts share features with fibroblasts but also with smooth muscle cells, and are usually identified by α-SMA (Roman, 2023).
“Fibroblast activity is always beneficial”
Proliferation and matrix deposition are part of normal repair, but when healing is unregulated they contribute to disease such as idiopathic pulmonary fibrosis (Roman, 2023).
FAQ
What are the main functions of fibroblasts?
Producing the ECM core components such as collagens and fibronectin, taking part in every stage of wound healing, communicating with immune cells after injury, and, when repair is unregulated, driving fibrosis.
What are the functions of fibroblasts in wound healing?
They invade and proliferate at the wound, deposit ECM including early fibronectin, and contribute to scar formation and contraction (Roman, 2023; Knoedler et al., 2023).
Do all fibroblasts do the same thing?
No. Origin, plasticity and function vary, and one study of human skin samples identified four distinct populations (Philippeos et al., as reported in Knoedler et al., 2023).
What is the difference between a fibroblast and a myofibroblast?
A myofibroblast combines fibroblast and smooth muscle features, with α-SMA as the best-known marker (Roman, 2023).
Sources
- Roman J. Fibroblasts – Warriors at the Intersection of Wound Healing and Disrepair. Biomolecules 2023;13(6):945. doi:10.3390/biom13060945. pmc.ncbi.nlm.nih.gov/articles/PMC10296409 (checked 2026-10-29).
- Knoedler S et al. Fibroblasts – the cellular choreographers of wound healing. Front Immunol 2023;14. doi:10.3389/fimmu.2023.1233800. frontiersin.org (checked 2026-10-29).
